Rongzhen Luo

1.8k citations
55 papers · 1.1k indexed · h-index 19
Topics
Cancer Immunotherapy and Biomarkers (8 papers)Cancer-related gene regulation (5 papers)Endometrial and Cervical Cancer Treatments (5 papers)
Journals
Nature CommunicationsSHILAP Revista de lepidopterologíaPLoS ONE

In The Last Decade

Rongzhen Luo

52 papers receiving 1.1k citations

Peers

Rongzhen Luo
Comparison fields: 5 of 100
  • Molecular Biology 482
  • Oncology 460
  • Cancer Research 262
  • Immunology 207
  • Pulmonary and Respiratory Medicine 191
Replace Girieca Lorusso with:
Girieca Lorusso Switzerland
Shanming Ruan China
Jinglei Qu China
Hong Zhu China
Hye Won Lee South Korea
Ji Nie China
Italia Falcone Italy
Hwang‐Phill Kim South Korea
Bingyin Shi China
Yan Yu China
Rongzhen Luo relative to Girieca Lorusso Switzerland Girieca Lorusso's profile →
Citations per field
00.5×1.5×2.3×
Girieca Lorusso · 1×
Citations per year

Countries citing papers authored by Rongzhen Luo

Since Specialization
Citations

This map shows the geographic impact of Rongzhen Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rongzhen Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rongzhen Luo more than expected).

Fields of papers citing papers by Rongzhen Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rongzhen Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rongzhen Luo. The network helps show where Rongzhen Luo may publish in the future.

Co-authorship network of co-authors of Rongzhen Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Rongzhen Luo. A scholar is included among the top collaborators of Rongzhen Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rongzhen Luo. Rongzhen Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 4
3 13
4 10
5 12
6 12
7 39
8 11
9 13
10 5
11 40
12 5
13 4
14 27
15 31
16 12
17 11
18 7
19 33
20 36

About Rongzhen Luo

Rongzhen Luo is a scholar working on Oncology, Cancer Research and Obstetrics and Gynecology, having authored 55 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Cancer-related gene regulation (5 papers) and Endometrial and Cervical Cancer Treatments (5 papers). The work is most often cited by research in Cancer Research (262 citations), Oncology (460 citations) and Immunology (207 citations). Rongzhen Luo has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Zhongyu Yuan, Shusen Wang, Roujun Peng, Cong Xue, Jing‐Ping Yun, Lili Liu, Xue Chao, Yue-Li Sun, Haixia Jiang and Jie‐Qiong Ma. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026